Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is for people with triple negative breast cancer that has come back (recurrent) or spread to another part of the body (metastatic).
Triple negative breast cancers are cancers without for:
oestrogen
progesterone
HER2
Recruitment start: 27 July 2016
Recruitment end: 30 March 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Peter Schmid
Merck Sharp & Dohme Ltd
Last reviewed: 31 Jul 2018
CRUK internal database number: 14853